Villetes, Ricardo .
HRN: 23-52-46 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/12/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/12/2023
08/18/2023
IVT
500mg
Q8
T/C Tetanus Infection
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes